Allen Chao - Tanvex BioPharma Chairman

6541 Stock  TWD 65.70  1.30  1.94%   

Chairman

Allen Chao is Chairman of the Board, Chief Executive Officer, General Manager of Tanvex BioPharma since 2020.
Tenure 4 years
Webhttps://www.tanvex.com

Tanvex BioPharma Management Efficiency

The company has return on total asset (ROA) of (0.2041) % which means that it has lost $0.2041 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.603) %, meaning that it generated substantial loss on money invested by shareholders. Tanvex BioPharma's management efficiency ratios could be used to measure how well Tanvex BioPharma manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Found 4 records

CHAIRMAN Age

Michael ChangOBI Pharma
73
Tamon TsengOBI Pharma
N/A
ChiChuan ChenTaiMed Biologics
N/A
James ChangTaiMed Biologics
N/A
Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar and biologic products and drugs in Taiwan and the United States. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands. TANVEX BIOPHARMA is traded on Taiwan Stock Exchange in Taiwan. Tanvex BioPharma (6541) is traded on Taiwan Stock Exchange in Taiwan and employs 23 people.

Management Performance

Tanvex BioPharma Leadership Team

Elected by the shareholders, the Tanvex BioPharma's board of directors comprises two types of representatives: Tanvex BioPharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tanvex. The board's role is to monitor Tanvex BioPharma's management team and ensure that shareholders' interests are well served. Tanvex BioPharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tanvex BioPharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lin Chen, Chief Executive Officer, Chief Financial Officer, Head of Finance, Director
Val Chen, Director Officer
Helena Makagiansar, Deputy General Manager-LJB Production Development
Yongjian Wu, Deputy General Manager-LJB Research & Development
LungYeh Cho, Director
Dilip Joshi, VP US
LeeChiou Chang, Independent Director
FACP FACP, Pres Chairman
Lily Yuan, Site LJB
K Lin, Co CFO
Linda Grillo, Director Marketing
Zheng Xia, Chief Officer
Mike Parker, Senior Deputy General Manager-Technology
ChiChuan Chen, Chairman of the Board
Allen Chao, Chairman of the Board, Chief Executive Officer, General Manager
Yun Yen, Director
David Hsia, Chief Technology Officer, Director
Kaiwen Yang, Deputy General Manager-LJB Production
Tamon Tseng, Director
Chuan Shih, Independent Director
JinPau Tsai, Independent Director

Tanvex Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tanvex BioPharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tanvex Stock Analysis

When running Tanvex BioPharma's price analysis, check to measure Tanvex BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tanvex BioPharma is operating at the current time. Most of Tanvex BioPharma's value examination focuses on studying past and present price action to predict the probability of Tanvex BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tanvex BioPharma's price. Additionally, you may evaluate how the addition of Tanvex BioPharma to your portfolios can decrease your overall portfolio volatility.